Molecularly Imprinted Membranes: Dual@MIPs@mbr for On-Site Detection of CA 19-9.

Dual-emission molecularly imprinted membranes (dual@MIPs@mbr) were developed as a proof-of-concept platform for the selective and instrument-free detection of the cancer biomarker carbohydrate antigen 19-9 (CA 19-9). The system integrates a ratiometric fluorescence response by embedding yellow-emitting quantum dots (y-QDs), serving as target-responsive probes, and blue-emitting carbon dots (b-CDs), acting as an internal reference, within a CA 19-9-imprinted polymeric matrix. Specific rebinding of CA 19-9 to the imprinted cavities induced selective quenching of the y-QDs while preserving the b-CDs emission, yielding a visible color shift from yellow/green to blue. This behavior enabled the quantification of CA 19-9 over a linear range of 4-400 U mL-1, with a limit of detection of 0.056 U mL-1 in diluted serum. The membranes showed good selectivity against common serum interferents and maintained short-term photochemical stability. Although the method has not yet been validated using real clinical samples, the pronounced ratiometric response and simple visual readout demonstrate its potential as a low-cost, portable sensing approach for future point-of-care cancer biomarker analysis.